coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    South & West Herefordshire PCN, Herefordshire, County of (LAD) · Health Inequalities Profile

    PCN U98974 · NHS Herefordshire and Worcestershire Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    43,689

    Registered population

    53.5% aged 18–64

    30.1%

    Aged 65+

    ICB 24.3% · England 17.9%

    2.3%

    Ethnic minority (non-White)

    0.7% Asian · England 9.6%

    4.0%

    In IMD quintile 1

    ICB 10.9% · England 21.0%

    ~1,522

    Core20 residents (est.)

    Resident basis; registered basis ~1,697 · see page 3

    8,533

    Hypertension register

    +4.67% in 3 yrs · England +5.60%

    322

    SMI register

    18.7% of Herefordshire, County of (LAD)'s

    1,017

    COPD register

    Reviews +12.57% in 3 yrs

    Forecast to 2030

    9,670

    Hypertension patients, 2030

    +1,137 on today

    89.8%

    QRISK ≥20% on statins, 2030

    +11.41pp over 3 yrs

    6.6%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    1,085
    Asthma patients without a recorded annual review.

    Annual asthma reviews cover 64.2% of the 3,029 register (England 65.7%, ICB 66.4%), leaving a scale gap of 1,085 unreviewed patients.

    57.9%
    High-risk QRISK patients on lipid-lowering therapy.

    Lipid-lowering therapy for patients with QRISK ≥ 20% stands at 57.9%, trailing Herefordshire (59.6%), the ICB (61.4%) and England (63.6%).

    73.4%
    Hypertension and diabetes control exceed national benchmarks.

    Blood pressure treatment to target reaches 73.4% (England 70.3%) and non-frail diabetes HbA1c control reaches 63.5% (England 57.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 30.1% of the list, well above England's 17.9%

    Patients aged 65+ make up 30.1% (13,150) of the 43,689 registered list, above Herefordshire LAD (28.3%), the ICB (24.3%) and England (17.9%). Working-age adults (18-64) account for 53.5% and children (0-17) 16.4%. Census resident estimates indicate 97.7% White ethnicity, against 96.9% in the LAD, 94.6% in the ICB and 81.1% in England, with an ethnic minority share of 2.3%. This older age structure is consistent with high frailty and chronic disease workload, though resident ethnicity figures do not capture practice-level registered patient diversity.

    Age profile

    0–1716.4%
    18–6453.5%
    65+30.1%

    65+: ICB 24.3%, England 17.9%

    Ethnicity

    White97.7%
    Mixed1.0%
    Asian0.7%
    Other0.4%
    Black0.2%

    Older people · falls rows are Herefordshire, County of (LAD) local-authority (LA) data, not PCN

    MeasureLocalWest MidlandsEnglandPeriod
    Falls admissions, 65+, per 100,000 (Herefordshire LA)1,4721,8471,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)84.6%—81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)63.5%—57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Herefordshire LA)7729229552024/25
    Falls deaths, all ages, per 100,000 (Herefordshire LA)10.417.514.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation affects 4.0% of patients and concentrates entirely in two practices

    The PCN Core20 share is 4.0%, below Herefordshire LAD (7.8%), the ICB (10.9%) and England (21.0%), with an average IMD decile of 5.6. Practice-level estimates (totalling 1,697 patients) and resident counts (1,522 across 1 decile-2 LSOA) reflect different bases and do not reconcile directly. Core20 workload concentrates entirely in Alton Street Surgery (9.8%, estimated 1,141 patients) and Pendeen Surgery (6.3%, 556 patients). Focusing preventative outreach on these two practices directs resources to the PCN's entire recorded Core20 cohort.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Alton Street9.8% · 1,141 patients
    Pendeen6.3% · 556 patients
    Golden Valley0.0% · 0 patients
    Much Birch0.0% · 0 patients
    Kingstone0.0% · 0 patients
    Fownhope0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    322

    SMI register

    0.73% recorded prevalence

    250

    Learning disability register

    0.57% recorded prevalence

    26

    Care homes, 612 beds

    In the PCN catchment

    8.7%

    Provide unpaid care

    Herefordshire, County of (LAD), Census 2021

    The PCN records 250 learning disability patients (0.6%, matching England's 0.6%) and 322 severe mental illness patients (0.7%, below England's 1.0%), alongside 26 catchment care homes with 612 beds. Across Herefordshire local authority, Census data recorded 8.7% unpaid carers, and the rough sleeping snapshot was 16 people in autumn 2025. Crude recorded prevalence does not establish unmet need or under-detection.

    Severe mental illness: physical health checks

    Across 322 SMI patients, annual checks trail England on blood pressure (80.2% vs 83.4%), BMI (78.4% vs 82.1%), and alcohol recording (75.1% vs 81.8%). Prioritising combined physical health clinics could close these component gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,533

    Hypertension register

    +4.67%

    Register growth, 3 yrs

    Herefordshire, County of (LAD) +10.36% · England +5.60%

    +6.31pp

    BP control, under 80

    ≤140/90 · +3.74pp aged 80+

    +1,137

    More patients by 2030

    Forecast 9,670 (21.28%)

    Hypertension case-finding and control

    Hypertension prevalence is 19.4% (8,533 patients), above England (15.2%), LAD (19.2%) and ICB (18.7%), with three-year growth of +4.7% (England +5.6%). Blood pressure treated to target reaches 73.4%, exceeding England (70.3%), LAD (68.6%) and ICB (70.4%), leading national rates in patients aged under 80 (70.2% vs 67.8%) and 80+ (82.9% vs 81.2%). However, recent blood pressure checks cover 89.6%, below England (90.0%), LAD (90.3%) and ICB (90.6%), with three-year recording growth (+1.9%) trailing England (+3.6%). While blood pressure control is well maintained, slower monitoring growth points to an opportunity to tighten annual blood pressure recall across this large caseload.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy coverage is 57.9%, trailing England (63.6%), LAD (59.6%) and ICB (61.4%), despite +24.6% three-year growth (England +6.2%). In CKD, coverage reaches 69.0% (England 70.3%). Fewer high-risk patients receive lipid therapy than national benchmarks, making proactive QRISK recall a priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026103,386£2.30£2.17£1.86£237,788
    Cardiovascular (all), 2025127,766£4.38£4.41£3.33£559,615

    In 2026, the PCN prescribed 103,386 lipid-regulating items at £2.30 per item (annual spend £237,788), compared with £1.86 in England, £2.44 in the LAD and £2.17 in the ICB. Across 103,386 items, this is £45,490 more than at England's unit cost. Higher unit costs than England suggest reviewing drug selection while maintaining clinical coverage.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +3.95%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +3.67%

    Asthma prevalence, PCN 3-yr % change

    COPD annual reviews reached 77.1% across 1,017 registered patients (prevalence 2.3%), up +12.6% over 2023 to 2025 (England +2.8%). Asthma reviews covered 64.2% of 3,029 patients (England 65.7%, ICB 66.4%), leaving an estimated 1,085 patients without a recorded review, while paediatric asthma second-hand smoke recording reached 74.3% (226 patients; England 78.8%). Focused call-recall may help address unreviewed asthma patients.

    Cancer register and children's immunisation

    Cancer register prevalence is 5.4% (2,385 patients), exceeding England (3.8%). In Q1 2025/26, 12-month 6-in-1 coverage reached the 95.0% target at 95.0% (England 91.0%). However, age-5 coverage was below the 95.0% target: MMR dose 2 was 88.0% (7 pp below target) and 4-in-1 booster was 86.7% (8.3 pp below target). Proactive recall before school entry could help lift preschool booster uptake.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.0%

    England 91.0%

    6-in-1 complete primary course at 24 months94.7%

    England 92.2%

    MMR dose 1 at 24 months93.3%

    England 88.3%

    MMR dose 2 at age 588.0%

    England 82.8%

    4-in-1 pre-school booster at age 586.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    56.2%

    Herefordshire and Worcestershire ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~770

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Herefordshire and Worcestershire ICBEnglandNo usable stageStaged cancers
    Prostate52.4%53.2%23%706
    Bowel51.4%47.0%15%657
    Breast88.9%85.4%28%611
    Lung32.1%33.8%13%473
    Skin cancer86.3%87.8%13%314

    Across NHS Herefordshire and Worcestershire ICB in 2022, 56.2% of staged cancers (2,285 of 4,068) were diagnosed at stage 1 or 2, 18.8 pp below the 75.0% national ambition. Reaching 75.0% requires about 770 extra early diagnoses annually across the ICB, while early-stage share fell 2.7 pp between 2013 and 2022. Known-stage completeness was 68.0% (4,068 of 5,984 cancers). System figures reflect diagnostic staging rather than PCN performance. Meanwhile, PCN cervical screening coverage is 71.3% (England 66.8%), though Pendeen Surgery trails at 65.1% and Alton Street Surgery at 68.3%. Screening recall should prioritize practices trailing benchmarks.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026 (provisional), main acute provider Wye Valley NHS Trust achieved 85.1% on the 62-day referral-to-treatment standard, meeting the 85.0% standard and outperforming England (71.2%), Gloucestershire Hospitals NHS Foundation Trust (74.6%), and Worcestershire Acute Hospitals NHS Trust (53.0%), while NHS Herefordshire and Worcestershire Integrated Care Board stood at 61.7%. Wye Valley reached 86.5% on the 28-day faster diagnosis standard (ICB 83.0%; England 79.3%) and 96.2% on 31-day combined treatment. Diagnostic six-week waits at Wye Valley were 0.2% for computed tomography and 18.2% for magnetic resonance imaging.

    Pathways within standard (%)Wye ValleyGloucestershireWorcestershire AcuteHerefordshire and Worcestershire ICBEngland
    28-day faster diagnosis (75%)86.5274.4382.5083.0579.32
    31-day treatment (96%)96.2594.6686.9889.9592.50
    62-day referral to treatment (85%)85.1474.5952.9961.7171.16
    Diagnostic waits over 6 weeks (%)Wye ValleyGloucestershireWorcestershire AcuteEngland
    MRI18.2315.9622.5121.40
    CT0.167.4411.099.92
    Echocardiography30.2456.1710.2528.48
    Colonoscopy40.0040.009.9130.83
    Gastroscopy26.0931.559.5329.02
    All 15 DM01 tests19.3518.3430.6123.14
    Community services activityHerefordshire, County of residentsHerefordshire and Worcestershire ICB
    Care contacts43,135124,085
    Referrals5,97023,130
    Patients with a contact9,55030,665

    Community services (residents of Herefordshire, County of), Jun 2026 (provisional). In the Community Services Dataset for June 2026 (provisional), 67.4% of community service contacts for Herefordshire local authority residents were with adults aged 65 and over (29,080 of 43,135 total contacts). This activity captures authority residents rather than specific PCN cohorts.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    GP contact ease spans 21.8 pp and vaccination achievement varies by 58.2 pp

    All six practices achieved 100.0% in QOF clinical (England 97.1%). Overall points ranged from 91.3% at Much Birch Surgery to 98.0% at Golden Valley Practice. Vaccination achievement spanned 58.2 pp; Much Birch Surgery reached 23.7% and Alton Street Surgery reached 48.0%, trailing England (55.2%). Personalized care adjustment rates spanned 5.2% at Golden Valley Practice to 11.2% at Pendeen Surgery.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Kingstone1240.093.9%78.6%97.6%
    Golden Valley990.076.6%75.8%88.7%
    Alton Street1239.878.5%71.7%88.5%
    Much Birch Surgery1020.088.6%79.1%88.1%
    Pendeen Surgery1156.372.1%74.1%83.4%
    Fownhope1170.078.9%71.6%78.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHerefordshire, County of (LAD)AssetPCNHerefordshire, County of (LAD)
    Care homes (catchment)26 (612 beds)n/aSchools (catchment)56n/a
    Children's centres17Places of worship162341
    Libraries19Day centres (VCS)n/a1
    Carers support groups (VCS)n/a1Primary schools (LA maintained)1843
    Primary academies928Special schools14

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma annual review recall

    64.2% of the 3,029 asthma register had a review in the last 12 months (England 65.7%, LAD 64.8%, ICB 66.4%), leaving a scale gap of 1,085 patients. For discussion: the PCN could run standardised asthma recall and flexible clinics, starting in the two Core20 practices. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Bundled SMI physical health checks

    Across 322 SMI patients, annual checks trail England on BP (80.2% vs 83.4%), BMI (78.4% vs 82.1%) and alcohol recording (75.1% vs 81.8%); patient gap is not sized. For discussion: practices could offer bundled single-appointment SMI physical health checks and align template coding with mental health partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    High-risk QRISK lipid therapy recall

    Lipid-lowering therapy for QRISK ≥ 20% is 57.9% (incl. PCAs), trailing England (63.6%), LAD (59.6%) and ICB (61.4%); patient gap is not sized. For discussion: the PCN could run pharmacist-led recall of untreated QRISK ≥ 20% patients alongside a formulary review (£2.30 per item vs England £1.86). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Anticipatory frailty reviews (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Hypertension patients with a recent blood pressure readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake improvement (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Primary care telephony access review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)Core20PLUS5 respiratoryPCN & Practice
    Option 2 · Bundled SMI physical health checks (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · Record of a BP check in the last 12 months for patients on the MH register (denominator incl. PCAs)MHIS · From Harm to HopePCN
    Option 3 · High-risk QRISK lipid therapy recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Cost per item for Lipid-regulating drugs 2026Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15